Format

Send to

Choose Destination
Am J Health Behav. 2014 Mar;38(2):265-74. doi: 10.5993/AJHB.38.2.12.

Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system.

Author information

1
Los Angeles Clinical Trials, Burbank, CA. Scott J. Leischow, Mayo Clinic, Scottsdale, AZ, USA. mnides@laclinicaltrials.com.
2
Los Angeles Clinical Trials, Burbank, CA. Scott J. Leischow, Mayo Clinic, Scottsdale, AZ, USA.

Abstract

OBJECTIVES:

To evaluate nicotine delivery from the NJOY® King Bold Electronic Nicotine Delivery System (ENDS) and its short-term potential for smoking reduction or cessation.

METHODS:

One week of ad libitum use was followed by measurements of plasma nicotine, heart rate, and craving and withdrawal after 12 hours of nicotine abstinence in 25 adult smokers not interested in quitting.

RESULTS:

After 5 minutes of use, blood nicotine levels increased by a mean of 3.5 ng/mL (p < .001), heart rate increased, and craving was reduced by 55%. Cigarettes per day were reduced by 39% during the test week, and perceptions of use for reduction or cessation were positive.

CONCLUSIONS:

The NJOY® King Bold ENDS delivers nicotine and led to short-term smoking reduction.

PMID:
24629555
DOI:
10.5993/AJHB.38.2.12
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ingenta plc
Loading ...
Support Center